scholarly article | Q13442814 |
P50 | author | Christopher D. Kontos | Q51600791 |
P2093 | author name string | Dawn Bowles | |
Joshua M Hare | |||
Howard A Rockman | |||
Jonathan S Stamler | |||
Diana L Diesen | |||
Liang Xie | |||
Jeffrey Nienaber | |||
Nestor Villamizar | |||
Brian Lima | |||
Emily Messina | |||
Gregory K W Lam | |||
P2860 | cites work | S-nitrosothiols signal hypoxia-mimetic vascular pathology | Q24675222 |
A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans | Q28205902 | ||
Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock | Q28246441 | ||
Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2 | Q28300709 | ||
Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
Protein S-nitrosylation: a physiological signal for neuronal nitric oxide | Q29615001 | ||
S-nitrosylation signaling in cell biology | Q30433042 | ||
Akt-mediated activation of HIF-1 in pulmonary vascular endothelial cells by S-nitrosoglutathione | Q30441190 | ||
Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction | Q30477341 | ||
Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy | Q33257976 | ||
A central role for S-nitrosothiols in plant disease resistance. | Q33841192 | ||
Regulation of HIF-1alpha stability through S-nitrosylation | Q34001616 | ||
S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood | Q34007606 | ||
Plant immunity requires conformational changes [corrected] of NPR1 via S-nitrosylation and thioredoxins | Q34012833 | ||
Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice | Q34961540 | ||
S-nitrosylation in health and disease | Q35119656 | ||
Nitric oxide and excitation-contraction coupling | Q35159059 | ||
S-Nitrosohemoglobin: an allosteric mediator of NO group function in mammalian vasculature | Q35837810 | ||
S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking | Q37070857 | ||
Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases | Q39855219 | ||
Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2. | Q40179416 | ||
HIF-1 alpha protein as a target for S-nitrosation | Q40673725 | ||
Fas-induced caspase denitrosylation | Q40958925 | ||
Dynamics of the hypoxia-inducible factor-1-vascular endothelial growth factor promoter complex | Q42519801 | ||
Inhibition of N-ethylmaleimide-sensitive factor protects against myocardial ischemia/reperfusion injury | Q42873483 | ||
Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase | Q45091743 | ||
Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury | Q46882604 | ||
Effects of Nitroglycerin on Erythrocyte Rheology and Oxygen Unloading | Q57450320 | ||
Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells | Q58816342 | ||
S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control | Q59054161 | ||
Blood traffic control | Q59054300 | ||
Competitive displacement of phosphoinositide 3-kinase from β-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling | Q60197041 | ||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6297-6302 | |
P577 | publication date | 2009-03-26 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Endogenous S-nitrosothiols protect against myocardial injury | |
P478 | volume | 106 |
Q35195295 | A new paramagnetic intermediate formed during the reaction of nitrite with deoxyhemoglobin |
Q39419240 | A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma |
Q33931201 | A novel suppressive effect of alcohol dehydrogenase 5 in neuronal differentiation |
Q37761772 | A rapid approach for the detection, quantification, and discovery of novel sulfenic acid or S-nitrosothiol modified proteins using a biotin-switch method. |
Q33663800 | Adenosine A1 receptor activation increases myocardial protein S-nitrosothiols and elicits protection from ischemia-reperfusion injury in male and female hearts |
Q36637584 | Adult mesenchymal stem cells and the NO pathways |
Q38964420 | An NO/GSNO-based Neuroregeneration Strategy for Stroke Therapy |
Q89482547 | An emerging perspective on sex differences: Intersecting S-nitrosothiol and aldehyde signaling in the heart |
Q33791710 | Analysis of nitroso-proteomes in normotensive and severe preeclamptic human placentas |
Q36220974 | Can nitric oxide-based therapy prevent bronchopulmonary dysplasia? |
Q36420890 | Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion |
Q36252927 | Cardiovascular redox and ox stress proteomics |
Q28304250 | Characterization of potential S-nitrosylation sites in the myocardium |
Q36699587 | Characterization of the sex-dependent myocardial S-nitrosothiol proteome. |
Q41413474 | Chasing cysteine oxidative modifications: proteomic tools for characterizing cysteine redox status |
Q90357271 | Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI |
Q37458706 | Commentary: mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma |
Q30432944 | Compartmentalized connexin 43 s-nitrosylation/denitrosylation regulates heterocellular communication in the vessel wall |
Q35651454 | Contribution of Fdh3 and Glr1 to Glutathione Redox State, Stress Adaptation and Virulence in Candida albicans |
Q37671204 | Convergence of G protein-coupled receptor and S-nitrosylation signaling determines the outcome to cardiac ischemic injury |
Q38088893 | Crosstalk between oxygen- and nitric oxide-dependent signaling pathways in angiogenesis |
Q83901362 | Different effects of SNP and GSNO on mitochondrial O2 .- /H 2O2 production |
Q35556440 | Disruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins |
Q24655038 | Dissection of a hypoxia-induced, nitric oxide-mediated signaling cascade |
Q35837215 | Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function |
Q33901272 | Endogenous NO upon estradiol-17β stimulation and NO donor differentially regulate mitochondrial S-nitrosylation in endothelial cells |
Q35132755 | Endothelial ephrin-B2 is essential for arterial vasodilation in mice |
Q46427869 | Enhanced Aerobic Glycolysis by S-Nitrosoglutathione via HIF-1α Associated GLUT1/Aldolase A Axis in Human Endothelial Cells |
Q36048495 | Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease |
Q41918404 | Established Principles and Emerging Concepts on the Interplay between Mitochondrial Physiology and S-(De)nitrosylation: Implications in Cancer and Neurodegeneration. |
Q33592650 | Estradiol-17beta stimulates specific receptor and endogenous nitric oxide-dependent dynamic endothelial protein S-nitrosylation: analysis of endothelial nitrosyl-proteome |
Q33837078 | Estrogen-responsive nitroso-proteome in uterine artery endothelial cells: role of endothelial nitric oxide synthase and estrogen receptor-β |
Q35119810 | Exercise protects against myocardial ischemia-reperfusion injury via stimulation of β(3)-adrenergic receptors and increased nitric oxide signaling: role of nitrite and nitrosothiols |
Q37881660 | G protein-coupled receptor kinases in normal and failing myocardium |
Q39250264 | GSNO promotes functional recovery in experimental TBI by stabilizing HIF-1α. |
Q38412593 | GSNOR Deficiency Enhances In Situ Skeletal Muscle Strength, Fatigue Resistance, and RyR1 S-Nitrosylation Without Impacting Mitochondrial Content and Activity |
Q34241559 | Glutaredoxin-1 overexpression enhances neovascularization and diminishes ventricular remodeling in chronic myocardial infarction |
Q37603613 | Hemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation |
Q41600066 | Hypoxia decreases creatine uptake in cardiomyocytes, while creatine supplementation enhances HIF activation. |
Q39374463 | Hypoxia inducible factor-1 alpha stabilization for regenerative therapy in traumatic brain injury |
Q35751684 | Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay |
Q34121401 | Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure |
Q34623553 | Importance of NO and its related compounds in enteric nervous system regulation of gut homeostasis and disease susceptibility |
Q34093559 | Increased stability of S-nitrosothiol solutions via pH modulations. |
Q37452579 | Increased susceptibility to Klebsiella pneumonia and mortality in GSNOR-deficient mice |
Q37825687 | Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease |
Q34757786 | Lymphocyte development requires S-nitrosoglutathione reductase |
Q42787699 | Membrane transfer of S-nitrosothiols |
Q38102887 | Methods for detection and characterization of protein S-nitrosylation |
Q36758527 | Minicircle DNA-mediated endothelial nitric oxide synthase gene transfer enhances angiogenic responses of bone marrow-derived mesenchymal stem cells |
Q27001094 | NADPH oxidases in heart failure: poachers or gamekeepers? |
Q42475814 | NO control: nitric oxide directly regulates substrate delivery to NOS. Focus on "Nitric oxide can acutely modulate its biosynthesis through a negative feedback mechanism on L-arginine transport in cardiac myocytes". |
Q33566513 | Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation. |
Q37986339 | Nitric oxide signaling in hypoxia |
Q26830146 | Nitric oxide synthases in heart failure |
Q38112049 | Nitric oxide transport in blood: a third gas in the respiratory cycle |
Q37887771 | Nitric oxide: a guardian for vascular grafts? |
Q38318607 | Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases. |
Q96304123 | Osteoimmune Modulation and Guided Osteogenesis Promoted by Barrier Membranes Incorporated with S-Nitrosoglutathione (GSNO) and Mesenchymal Stem Cell-Derived Exosomes |
Q59329156 | Pathophysiological Role of S-Nitrosylation and Transnitrosylation Depending on S-Nitrosoglutathione Levels Regulated by S-Nitrosoglutathione Reductase |
Q37484903 | Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation |
Q39558562 | Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo |
Q43245260 | Pharmacologically augmented S-nitrosylated hemoglobin improves recovery from murine subarachnoid hemorrhage |
Q38846185 | Post-translational modifications in mitochondria: protein signaling in the powerhouse |
Q35408828 | Priming of hypoxia-inducible factor by neuronal nitric oxide synthase is essential for adaptive responses to severe anemia |
Q35535466 | Promoting endothelial function by S-nitrosoglutathione through the HIF-1α/VEGF pathway stimulates neurorepair and functional recovery following experimental stroke in rats |
Q47410870 | Protein S-Nitrosylation: Determinants of Specificity and Enzymatic Regulation of S-Nitrosothiol-Based Signaling. |
Q35020178 | Protein S-nitrosylation in health and disease: a current perspective |
Q43279398 | Protein denitrosylation: enzymatic mechanisms and cellular functions. |
Q35890903 | Proteomic characterization of the cellular response to nitrosative stress mediated by s-nitrosoglutathione reductase inhibition. |
Q38478574 | ROS signaling and redox biology in endothelial cells |
Q38193013 | ROS signalling between endothelial cells and cardiac cells |
Q27004547 | Redox balance dynamically regulates vascular growth and remodeling |
Q34193659 | Redox regulatory mechanism of transnitrosylation by thioredoxin. |
Q35763044 | Regulation by S-nitrosylation of protein post-translational modification |
Q35206885 | Regulation of DNA repair by S-nitrosylation |
Q24300987 | Regulation of cardiovascular cellular processes by S-nitrosylation |
Q37168349 | Regulation of protein function and signaling by reversible cysteine S-nitrosylation. |
Q35948515 | Role of reactive oxygen and nitrogen species in the vascular responses to inflammation |
Q37091606 | Role of β-adrenergic receptors and nitric oxide signaling in exercise-mediated cardioprotection |
Q39533224 | S-Nitrosoglutathione Attenuates Airway Hyperresponsiveness in Murine Bronchopulmonary Dysplasia |
Q36168777 | S-Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial Infarction |
Q90668211 | S-Nitrosoglutathione Reductase Is Essential for Protecting the Female Heart From Ischemia-Reperfusion Injury |
Q37792924 | S-Nitrosothiol biology and therapeutic potential in metabolic disease. |
Q37223016 | S-Nitrosylation Proteome Profile of Peripheral Blood Mononuclear Cells in Human Heart Failure |
Q36144903 | S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy |
Q36079230 | S-Nitrosylation of cardiac ion channels |
Q41981524 | S-glutathionylation: a redox-sensitive switch participating in nitroso-redox balance |
Q36637366 | S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells |
Q88473015 | S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis |
Q35408904 | S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis |
Q36921356 | S-nitrosoglutathione. |
Q39181217 | S-nitrosothiol signaling regulates liver development and improves outcome following toxic liver injury |
Q34677895 | S-nitrosothiol signals in the enteric nervous system: lessons learnt from big brother |
Q34500513 | S-nitrosylation Inhibits protein kinase C-mediated contraction in mouse aorta |
Q24630263 | S-nitrosylation in cardiovascular signaling |
Q35492444 | S-nitrosylation in the regulation of gene transcription |
Q42462846 | S-nitrosylation of Cofilin-1 Serves as a Novel Pathway for VEGF-Stimulated Endothelial Cell Migration |
Q37637150 | S-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death. |
Q42232104 | S-nitrosylation of proteins: a new insight into endothelial cell function regulated by eNOS-derived NO. |
Q35693498 | S-nitrosylation: a radical way to protect the heart |
Q36497166 | S-nitrosylation: integrator of cardiovascular performance and oxygen delivery |
Q37204147 | S-nitrosylation: specificity, occupancy, and interaction with other post-translational modifications |
Q36232644 | SNOs Differ: Methodological and Biological Implications |
Q36106686 | Selective β2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury |
Q38179749 | Signaling by S-nitrosylation in the heart |
Q34590481 | Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture |
Q30419462 | Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice |
Q92938164 | Sodium nitrite improves hypertension-induced myocardial dysfunction by mechanisms involving cardiac S-nitrosylation |
Q37204142 | Specificity in S-nitrosylation: a short-range mechanism for NO signaling? |
Q36318326 | Stimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion |
Q35083525 | Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyltransferase and increased sensitivity to genotoxic diethylnitrosamine |
Q28396481 | The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironment |
Q26823143 | The identification of nitric oxide as endothelium-derived relaxing factor |
Q36347434 | The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke |
Q39231089 | The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy |
Q35222209 | Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies. |
Q35956677 | Thioredoxin-1 regulates cellular heme insertion by controlling S-nitrosation of glyceraldehyde-3-phosphate dehydrogenase |
Q36848221 | Transnitrosylation: A Factor in Nitric Oxide-Mediated Penile Erection. |
Q30415114 | Ventilatory responses during and following exposure to a hypoxic challenge in conscious mice deficient or null in S-nitrosoglutathione reductase |
Q34187849 | What can we learn about cardioprotection from the cardiac mitochondrial proteome? |
Q36312524 | β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury |
Search more.